Skip Nav Destination
Issues
1 March 2004
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Issue Sections
ARTICLE
A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes
Chunhua Qin; Derek Morrow; Jessica Stewart; Kyle Spencer; Weston Porter; Roger Smith, III; Timothy Phillips; Maen Abdelrahim; Ismael Samudio; Stephen Safe
Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines
Sandra Huguenin; Francis Vacherot; Laurence Kheuang; Jocelyne Fleury-Feith; Marie-Claude Jaurand; Manlio Bolla; Jean-Pierre Riffaud; Dominique K. Chopin
Commentary
Minireview
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.